Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer

Antonelli L.,Ardizzone D.,Tachibana I.,Adra N.,Cary C.,Sexton W.J.,Bagrodia A.,Mego M.,Daneshmand S.,Nicolai N.,Nazzani S.,Heidenreich A.,Paffenholz P.,Saoud R.,Eggener S.,Oswald N.,Tryakin A., Naoun N.,Cazzaniga W.,Nicol D.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology（2024）

引用 0|浏览12

暂无评分

摘要

Men with a complete resection at pcRPLND and <10% viable cells have favorable outcomes without further treatment. Complete retroperitoneal resection seems more important than early pcRPLND.

查看译文

关键词

nonseminomatous testicular cancer,viable residual cancer,relapse

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要